References
- Loeb L, Friedman H. Exophthalmos produced by injections of acid extract of anterior pituitary gland of cattle. Proc Soc Exp Biol Med 1932; 29: 648–650
- Albert A. The experimental production of exophthalmos in fundulus by means of anterior pituitary extracts. Endocrinology 1945; 37: 389–406
- Kohn L D, Winand R J. Structure of an exophthalmos-producing factor derived from thyrotropin by partial pepsin digestion. J Biol Chem 1975; 250: 6503–6508
- Kodama K, Bandy-Dafoe P, Sikorska H, Bayly R, Wall J R. Demonstration of a circulating autoantibody against a soluble eye muscle antigen in Graves' ophthalmopathy. Lancet 1982; 2: 1353–1356
- Kendall-Taylor P, Atkinson S, Holcombe M. A specific IgG in Graves' ophthalmopathy and its relation to retro-orbital and thyroid autoimmunity. Br Med J 1984; 288: 1183–1186
- Zhang Z-G, Medeiros-Neto G, Iacona A, Lima N, Hiromatsu Y, Salvi M, et al. Studies of cytotoxic antibodies against eye muscle antigens in patients with thyroid-associated ophthalmopathy. Acta Endocrinol 1989; 121: 23–30
- Hiromatsu Y, Cadarso L, Salvi M, Wall J R. Significance of cytotoxic eye muscle antibodies in patients with thyroid-associated ophthalmopathy. Autoimmunity 1990; 5: 205–213
- Hiromatsu Y, Wang P W, Wosu L, How J, Wall J R. Mechanisms of immune damage in Graves' ophthalmopathy. Hormone Res 1987; 26: 198–207
- DeGroot L J, Larsen P R, Refetoff S, Stanbury J B. Graves' disease: complications. Ch 8. The Thyroid and its Diseases5th edn. John Wiley & Sons, New York 1984; 462
- Wall J R. Autoimmunity and Graves' ophthalmopathy. The Eye and the Orbit in Thyroid Disease, C Gorman, J R Wall, J A Dyer. Raven Press, New York 1984; 103–119
- Wall J R, Salvi M, Bernard N. Eye disease and autoimmune thyroid disorders: mechanism for the association. Pathogenesis and Management of Graves' Ophthalmopathy. Contemporary Issues in Endocrinology and Metabolism, J R Wall, J How. Blackwell Scientific Publications Inc, Oxford 1990; 63–77
- Bauer F K, Catz B. Radioactive iodine therapy for progressive malignant exophthalmos. Acta Endocrinol 1966; 51: 15–22
- Werner S C, Feind C R, Aida M. Graves' disease and total thyroidectomy. Progression of severe eye changes and decrease in serum longacting thyroid stimulator after operation. N Engl J Med 1967; 276: 132–138
- Volpe R, Desbarats-Schonbaum M-L, Schonbaum E, Row V, Ezrin C. The effect of radioablation of the thyroid gland in Graves' disease with high levels of long-acting thyroid stimulator (LATS). Am J Med 1969; 46: 217–226
- Tallstedt L, Lundell G, Torring O, Wallin G, Ljunggren J-G, Blomgren H, et al. Occurrence of ophthalmopathy after treatment for Graves' hyperthyroidism. N Eng J Med 1992; 326: 1733–1738
- DeGroot L J, Mangklabruks A, McCormick M. Comparison of RA131I treatment protocols for Graves' disease. J Endocrinol Invest 1990; 13: 111–118
- Sridama V, DeGroot L J. Treatment of Graves' disease and the course of ophthalmopathy. Am J Med 1989; 87: 70–73
- Fenzi G, Hashizume K, Roudebush C, DeGroot L J. Changes in thyroid stimulating immunoglobulins during antithyroid therapy. J Clin Endocrinol Metabol 1979; 48: 572–576
- Soliman M, Kaplan E L, Abdel-Latif A, Scherberg N, DeGroot L J. Does thyroidectomy, RAI therapy, or antithyroid drug treatment alter reactivity of patient's T cells to epitopes of thyrotropin receptor in autoimmune thyroid disease?. J Clin Endocrinol Metabol 1995; 80: 2312–2321